FutureHouse
Coverage of FutureHouse in the Nexus archive.
- STAT+: AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs
Edison Scientific, a spin-off from AI scientist company FutureHouse, was created in late 2025 with $70 million in venture funding after pharmaceutical companies showed interest in their AI agents for drug discovery. FutureHouse, founded in 2023 by Sam Rodriques and Andrew White, initially aimed to scale scientific discovery through AI agents but pivoted to a commercial product due to demand from the pharmaceutical industry.
- Two AI-based science assistants succeed with drug-retargeting tasks
Two AI-based science assistants, Google's Co-Scientist and FutureHouse's system, have succeeded in drug-retargeting tasks by helping scientists develop and test hypotheses. The systems are designed to assist scientists in evaluating biological data and generating new hypotheses. Both systems operate in the background and are focused on addressing the issue of overwhelming scientific information.